Showing results (11-20 of 268) with videos related to
Sort By:
Pageof 27
DNA and Cell Biology|March 29, 2011
Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genesJuan Carlos Yugar-Toledo, José Fernando Vilela Martin, José Eduardo Krieger, et al.American Journal of Hypertension|July 27, 2014
Predictors of silent myocardial ischemia in resistant hypertensive patientsRodrigo Modolo, Ana Paula de Faria, Maria O Paganelli, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2006
Primary aldosteronism: diagnosis and treatmentEduardo Pimenta, David A CalhounCurrent Hypertension Reports|April 20, 2007
The role of aldosterone in resistant hypertension: implications for pathogenesis and therapyMurray Epstein, David A CalhounCardiovascular & Hematological Disorders Drug Targets|November 20, 2024
Exploring the Role of Prefrontal Cortex tDCS in Hypertension: A Mini-ReviewOlívia Moraes Ruberti, Heitor Moreno Junior, Bruno RodriguesCurrent Opinion in Nephrology and Hypertension|November 1, 2016
Refractory versus resistant hypertensionMohammed Siddiqui, David A CalhounCurrent Hypertension Reports|January 8, 2008
Resistant hypertension and aldosteronismEduardo Pimenta, David A CalhounAmerican Journal of Hypertension|September 10, 2016
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant HypertensionTanja Dudenbostel, David A CalhounCurrent Hypertension Reports|March 8, 2016
Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?Eduardo Pimenta, David A CalhounJournal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2011
Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diureticsMurray Epstein, David A CalhounPageof 27